Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Moodys
Colorcon
Daiichi Sankyo
Federal Trade Commission
Chinese Patent Office
Boehringer Ingelheim
McKinsey
Cipla
Cantor Fitzgerald

Generated: February 25, 2018

DrugPatentWatch Database Preview

Metoclopramide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for metoclopramide hydrochloride and what is the scope of metoclopramide hydrochloride patent protection?

Metoclopramide hydrochloride
is the generic ingredient in nine branded drugs marketed by Roxane, Emcure Pharms Ltd, Bedford, Fresenius Kabi Usa, Hospira, Lyphomed, Norbrook, Smith And Nephew, Teva Pharms Usa, West-ward Pharms Int, Actavis Mid Atlantic, Ani Pharms, Morton Grove, Paco, Pharm Assoc, Silarx, Teva, Vistapharm, Wockhardt Bio Ag, Robins Ah, Novel Labs Inc, Salix Pharms, Meda Pharms, Quantum Pharmics, King Pharms, Clonmel, Halsey, Impax Labs Inc, Interpharm, Ipca Labs Ltd, Mutual Pharm, Northstar Hlthcare, Par Pharm, Par Pharm Inc, Sandoz, Schering, Sun Pharm Industries, Superpharm, Usl Pharma, Vintage Pharms, Watson Labs, and Yaopharma Co Ltd, and is included in sixty-four NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Metoclopramide hydrochloride has sixteen patent family members in nine countries.

There are twelve drug master file entries for metoclopramide hydrochloride. Forty-five suppliers are listed for this compound.
Summary for metoclopramide hydrochloride
Pharmacology for metoclopramide hydrochloride
Medical Subject Heading (MeSH) Categories for metoclopramide hydrochloride

US Patents and Regulatory Information for metoclopramide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride TABLET;ORAL 070453-001 Jun 6, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride INJECTABLE;INJECTION 071990-001 Jan 18, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride INJECTABLE;INJECTION 070506-001 Jun 22, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Morton Grove METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride SOLUTION;ORAL 070949-001 Mar 6, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smith And Nephew METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride INJECTABLE;INJECTION 070622-001 Mar 2, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Robins Ah REGLAN metoclopramide hydrochloride SOLUTION;ORAL 018821-001 Mar 25, 1983 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride SOLUTION;ORAL 071402-001 Jun 25, 1993 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roxane METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride SOLUTION;ORAL 072038-001 Dec 5, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Yaopharma Co Ltd METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride TABLET;ORAL 074478-002 Oct 5, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage Pharms METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride TABLET;ORAL 077878-002 Aug 28, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for metoclopramide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Salix Pharms METOZOLV ODT metoclopramide hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 022246-002 Sep 4, 2009 ➤ Sign Up ➤ Sign Up
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-004 May 28, 1987 ➤ Sign Up ➤ Sign Up
Salix Pharms METOZOLV ODT metoclopramide hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 022246-001 Sep 4, 2009 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for metoclopramide hydrochloride

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
US Department of Justice
Express Scripts
Queensland Health
Argus Health
Cantor Fitzgerald
AstraZeneca
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot